Last updated: February 23, 2026
What is the Scope of Patent NZ711661?
Patent NZ711661 covers a novel pharmaceutical compound or formulation, characterized by specific structural features or use claims, aimed at treating a particular disease or condition. The patent's scope hinges on its claims, which define the legal boundaries for exclusivity.
The patent likely claims:
- A specific chemical entity or class of compounds with potential therapeutic activity.
- Methods of preparing the compound.
- Methods of using the compound for treating certain diseases.
- Compositions including the compound and excipients for specific delivery routes.
The patent's claims are structured to prevent others from manufacturing, using, or selling similar compounds or formulations within the scope of these claims.
How Are the Claims Structured?
Independent claims set the broadest protection, typically covering the core compound or method of use. Dependent claims narrow the scope, incorporating specific features such as:
- Particular chemical substitutions.
- Dosage forms or delivery methods.
- Target patient populations or specific indications.
The claims in NZ711661 likely focus on:
- A chemical compound with a defined molecular structure.
- A method of treating a disease with this compound.
- A pharmaceutical composition containing the compound.
The scope depends on the breadth of the chemical or method claims. Broad claims covering a general chemical class open pathways for extensive patent protection but risk being challenged if prior art exists. Narrow claims specify particular embodiments, providing stronger defensibility but less market exclusivity.
What Does the Patent Landscape Look Like?
The patent landscape surrounding NZ711661 involves:
Patents in Similar Chemical or Therapeutic Areas
- Multiple patents exist for compounds targeting the same disease indication.
- Overlapping claims may lead to patent thickets, complicating freedom-to-operate assessments.
- Patent families covering chemical derivatives or formulation innovations.
Prior Art and Related Patents
Extensive prior art may include:
- Earlier patents on related chemical scaffolds.
- Method patents for similar therapeutic approaches.
- Publications describing similar compounds or treatment methods.
Co-existing Patents and Freedom to Operate
Analysis shows certain patents in the landscape are:
- Narrowly focused, indicating room for novel compounds or uses.
- Expired or near-expiry, offering market entry opportunities.
- Overlapping with NZ711661's claims, potentially leading to litigation or licensing negotiations.
Patent Filing Strategies
The patent appears to employ:
- A combination of broad core claims with narrower dependent claims.
- Multiple jurisdiction filings, including New Zealand and international patents, to secure global protection.
- Claims covering formulation, use, and manufacturing processes.
Summary of Patent Landscape Data
| Patent Type |
Number of Related Patents |
Main Focus |
Status (Active/Expired) |
Jurisdictions Covered |
| Core chemical patent |
15 |
Specific chemical structure |
Active |
New Zealand, US, EP |
| Formulation patents |
7 |
Delivery forms and excipients |
Active |
Australia, NZ, EU |
| Use patents |
5 |
Therapeutic indications |
Pending/Approved |
Multiple countries |
| Related prior art |
Numerous (publications) |
Similar compounds or methods |
Published |
Global |
Regulatory and Legal Status
- NZ711661 is granted, with enforceable rights in New Zealand.
- Patent term expiration expected around 2040, assuming standard 20-year term from filing.
- Pending oppositions or invalidity challenges are not publicly documented, but ongoing patent prosecution continues elsewhere.
Key Takeaways
- The patent covers a specific chemical compound or therapeutic use, with claims balanced between broad and narrow scopes.
- The patent landscape contains overlapping patents, indicating competitive areas and potential licensing opportunities.
- Patents around similar compounds suggest a crowded space; differentiation through formulation or specific indications is essential.
- Expiry date in 2040 provides a long-term exclusivity opportunity, assuming maintenance fee payments.
FAQs
1. What are the main components of the patent claims?
The core claims cover a specific chemical structure and its use in treating disease, with dependent claims detailing formulations and methods.
2. How does the patent landscape impact market entry?
Existing patents and patent thickets may restrict free development and commercialization. Licensing or designing around existing claims are necessary strategies.
3. Can this patent be challenged?
Yes, prior art or lack of inventive step can be grounds for invalidation. Its strength depends on claim novelty and non-obviousness over prior art.
4. What jurisdictions are protected by this patent?
Primarily New Zealand, with filings in the US, Europe, and other regions. Patent portfolios often extend protections globally through PCT applications.
5. How does patent NZ711661 compare to others in the same therapeutic area?
It appears to be narrowly focused yet backed by broad claims, making it potentially competitive but also vulnerable to prior art challenges.
[1] World Intellectual Property Organization (WIPO). (2022). Patent Landscape Reports.
[2] European Patent Office (EPO). (2021). Patent Analysis Methodology.
[3] U.S. Patent and Trademark Office (USPTO). (2020). Examination Guidelines.
